nodes	percent_of_prediction	percent_of_DWPC	metapath
Calcitriol—Hypermagnesaemia—Epirubicin—liver cancer	0.0234	0.0556	CcSEcCtD
Calcitriol—Hypermagnesaemia—Doxorubicin—liver cancer	0.0217	0.0515	CcSEcCtD
Calcitriol—Rhinorrhoea—Sorafenib—liver cancer	0.00981	0.0233	CcSEcCtD
Calcitriol—Neoplasm malignant—Sorafenib—liver cancer	0.00931	0.0221	CcSEcCtD
Calcitriol—Hyperphosphataemia—Epirubicin—liver cancer	0.0086	0.0204	CcSEcCtD
Calcitriol—Hyperphosphataemia—Doxorubicin—liver cancer	0.00796	0.0189	CcSEcCtD
Calcitriol—Laboratory test abnormal—Epirubicin—liver cancer	0.00703	0.0167	CcSEcCtD
Calcitriol—Laboratory test abnormal—Doxorubicin—liver cancer	0.00651	0.0155	CcSEcCtD
Calcitriol—Pain in extremity—Sorafenib—liver cancer	0.00577	0.0137	CcSEcCtD
Calcitriol—Dehydration—Sorafenib—liver cancer	0.00537	0.0127	CcSEcCtD
Calcitriol—Urine abnormality—Epirubicin—liver cancer	0.00531	0.0126	CcSEcCtD
Calcitriol—Abdominal pain upper—Sorafenib—liver cancer	0.00527	0.0125	CcSEcCtD
Calcitriol—Aspartate aminotransferase increased—Sorafenib—liver cancer	0.0052	0.0123	CcSEcCtD
Calcitriol—Nasopharyngitis—Sorafenib—liver cancer	0.00516	0.0123	CcSEcCtD
Calcitriol—Urine analysis abnormal—Epirubicin—liver cancer	0.005	0.0119	CcSEcCtD
Calcitriol—Urine abnormality—Doxorubicin—liver cancer	0.00491	0.0117	CcSEcCtD
Calcitriol—Pancreatitis—Sorafenib—liver cancer	0.00489	0.0116	CcSEcCtD
Calcitriol—Serum creatinine increased—Epirubicin—liver cancer	0.00478	0.0113	CcSEcCtD
Calcitriol—Psoriasis—Epirubicin—liver cancer	0.00467	0.0111	CcSEcCtD
Calcitriol—Urine analysis abnormal—Doxorubicin—liver cancer	0.00462	0.011	CcSEcCtD
Calcitriol—Weight decreased—Sorafenib—liver cancer	0.00451	0.0107	CcSEcCtD
Calcitriol—Serum creatinine increased—Doxorubicin—liver cancer	0.00442	0.0105	CcSEcCtD
Calcitriol—Redness—Epirubicin—liver cancer	0.00435	0.0103	CcSEcCtD
Calcitriol—Psoriasis—Doxorubicin—liver cancer	0.00433	0.0103	CcSEcCtD
Calcitriol—Hypercalcaemia—Epirubicin—liver cancer	0.00423	0.01	CcSEcCtD
Calcitriol—Blister—Epirubicin—liver cancer	0.00408	0.00968	CcSEcCtD
Calcitriol—Redness—Doxorubicin—liver cancer	0.00403	0.00956	CcSEcCtD
Calcitriol—Haemoglobin—Sorafenib—liver cancer	0.00401	0.00953	CcSEcCtD
Calcitriol—Haemorrhage—Sorafenib—liver cancer	0.00399	0.00948	CcSEcCtD
Calcitriol—Albuminuria—Epirubicin—liver cancer	0.00394	0.00934	CcSEcCtD
Calcitriol—Hypercalcaemia—Doxorubicin—liver cancer	0.00391	0.00929	CcSEcCtD
Calcitriol—Erythema multiforme—Sorafenib—liver cancer	0.00378	0.00896	CcSEcCtD
Calcitriol—Blister—Doxorubicin—liver cancer	0.00377	0.00896	CcSEcCtD
Calcitriol—Albuminuria—Doxorubicin—liver cancer	0.00364	0.00865	CcSEcCtD
Calcitriol—CYP24A1—Biological oxidations—GSTA1—liver cancer	0.00359	0.00621	CbGpPWpGaD
Calcitriol—Arrhythmia—Sorafenib—liver cancer	0.00357	0.00847	CcSEcCtD
Calcitriol—CYP24A1—Biological oxidations—NAT2—liver cancer	0.00355	0.00614	CbGpPWpGaD
Calcitriol—VDR—Nuclear Receptors—PPARG—liver cancer	0.00353	0.00609	CbGpPWpGaD
Calcitriol—CYP3A4—Drug Induction of Bile Acid Pathway—NR1H4—liver cancer	0.00351	0.00607	CbGpPWpGaD
Calcitriol—CYP24A1—Metapathway biotransformation—NAT2—liver cancer	0.0035	0.00605	CbGpPWpGaD
Calcitriol—Erythema—Sorafenib—liver cancer	0.00348	0.00825	CcSEcCtD
Calcitriol—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I3—liver cancer	0.00345	0.00597	CbGpPWpGaD
Calcitriol—Neoplasm malignant—Epirubicin—liver cancer	0.00344	0.00817	CcSEcCtD
Calcitriol—Dysgeusia—Sorafenib—liver cancer	0.0034	0.00808	CcSEcCtD
Calcitriol—VDR—Nuclear Receptor transcription pathway—PPARA—liver cancer	0.00337	0.00583	CbGpPWpGaD
Calcitriol—CYP3A4—Farnesoid X Receptor  Pathway—NR1H4—liver cancer	0.00321	0.00555	CbGpPWpGaD
Calcitriol—Neoplasm malignant—Doxorubicin—liver cancer	0.00318	0.00756	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.00317	0.00548	CbGpPWpGaD
Calcitriol—Nocturia—Epirubicin—liver cancer	0.00317	0.00752	CcSEcCtD
Calcitriol—CYP24A1—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.00313	0.00541	CbGpPWpGaD
Calcitriol—Bone pain—Epirubicin—liver cancer	0.00307	0.00728	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.00306	0.00528	CbGpPWpGaD
Calcitriol—VDR—Nuclear Receptor transcription pathway—ESR1—liver cancer	0.00306	0.00528	CbGpPWpGaD
Calcitriol—VDR—Ovarian Infertility Genes—CDKN1B—liver cancer	0.00302	0.00521	CbGpPWpGaD
Calcitriol—Hypertension—Sorafenib—liver cancer	0.003	0.00713	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—TGFA—liver cancer	0.00299	0.00516	CbGpPWpGaD
Calcitriol—CYP24A1—Metapathway biotransformation—GPX3—liver cancer	0.00298	0.00515	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—ATF3—liver cancer	0.00296	0.00512	CbGpPWpGaD
Calcitriol—Myalgia—Sorafenib—liver cancer	0.00296	0.00703	CcSEcCtD
Calcitriol—CYP3A4—Aflatoxin B1 metabolism—GSTM1—liver cancer	0.00295	0.0051	CbGpPWpGaD
Calcitriol—Phosphatase alkaline increased—Epirubicin—liver cancer	0.00294	0.00698	CcSEcCtD
Calcitriol—Nocturia—Doxorubicin—liver cancer	0.00293	0.00696	CcSEcCtD
Calcitriol—Dry mouth—Sorafenib—liver cancer	0.00289	0.00687	CcSEcCtD
Calcitriol—VDR—Retinoic acid receptors-mediated signaling—MAPK8—liver cancer	0.00286	0.00494	CbGpPWpGaD
Calcitriol—CYP24A1—Biological oxidations—HPGDS—liver cancer	0.00284	0.00491	CbGpPWpGaD
Calcitriol—Bone pain—Doxorubicin—liver cancer	0.00284	0.00674	CcSEcCtD
Calcitriol—CYP3A4—Estrogen metabolism—GSTA1—liver cancer	0.00284	0.0049	CbGpPWpGaD
Calcitriol—Anaphylactic shock—Sorafenib—liver cancer	0.00284	0.00674	CcSEcCtD
Calcitriol—VDR—Nuclear Receptor transcription pathway—PPARG—liver cancer	0.00279	0.00482	CbGpPWpGaD
Calcitriol—Blood urea increased—Epirubicin—liver cancer	0.00277	0.00659	CcSEcCtD
Calcitriol—Skin disorder—Sorafenib—liver cancer	0.00276	0.00654	CcSEcCtD
Calcitriol—Phosphatase alkaline increased—Doxorubicin—liver cancer	0.00272	0.00646	CcSEcCtD
Calcitriol—VDR—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—liver cancer	0.00272	0.00469	CbGpPWpGaD
Calcitriol—Anorexia—Sorafenib—liver cancer	0.0027	0.00642	CcSEcCtD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.00263	0.00454	CbGpPWpGaD
Calcitriol—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00258	0.00614	CcSEcCtD
Calcitriol—Blood urea increased—Doxorubicin—liver cancer	0.00257	0.00609	CcSEcCtD
Calcitriol—VDR—RXR and RAR heterodimerization with other nuclear receptor—TNF—liver cancer	0.00254	0.00438	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—liver cancer	0.0025	0.00432	CbGpPWpGaD
Calcitriol—Decreased appetite—Sorafenib—liver cancer	0.00247	0.00585	CcSEcCtD
Calcitriol—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.00245	0.00582	CcSEcCtD
Calcitriol—Pain—Sorafenib—liver cancer	0.00243	0.00576	CcSEcCtD
Calcitriol—Constipation—Sorafenib—liver cancer	0.00243	0.00576	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.00234	0.00404	CbGpPWpGaD
Calcitriol—GC—Metabolism—UGDH—liver cancer	0.00233	0.00403	CbGpPWpGaD
Calcitriol—Gastrointestinal pain—Sorafenib—liver cancer	0.00232	0.00551	CcSEcCtD
Calcitriol—CYP24A1—Biological oxidations—CYP2E1—liver cancer	0.00232	0.004	CbGpPWpGaD
Calcitriol—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—liver cancer	0.00229	0.00395	CbGpPWpGaD
Calcitriol—CYP24A1—Metapathway biotransformation—CYP2E1—liver cancer	0.00228	0.00395	CbGpPWpGaD
Calcitriol—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.00227	0.00539	CcSEcCtD
Calcitriol—Urticaria—Sorafenib—liver cancer	0.00225	0.00535	CcSEcCtD
Calcitriol—Body temperature increased—Sorafenib—liver cancer	0.00224	0.00532	CcSEcCtD
Calcitriol—Abdominal pain—Sorafenib—liver cancer	0.00224	0.00532	CcSEcCtD
Calcitriol—VDR—Validated transcriptional targets of TAp63 isoforms—CDKN2A—liver cancer	0.00224	0.00387	CbGpPWpGaD
Calcitriol—Dermatitis bullous—Epirubicin—liver cancer	0.00223	0.0053	CcSEcCtD
Calcitriol—GC—Metabolism—EPT1—liver cancer	0.00219	0.00379	CbGpPWpGaD
Calcitriol—Pain in extremity—Epirubicin—liver cancer	0.00213	0.00506	CcSEcCtD
Calcitriol—CYP24A1—Biological oxidations—GGT1—liver cancer	0.00213	0.00367	CbGpPWpGaD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—ESR1—liver cancer	0.00211	0.00365	CbGpPWpGaD
Calcitriol—Hypersensitivity—Sorafenib—liver cancer	0.00209	0.00496	CcSEcCtD
Calcitriol—CYP3A4—Constitutive Androstane Receptor Pathway—NR1I3—liver cancer	0.00208	0.0036	CbGpPWpGaD
Calcitriol—GC—Metabolism—TAT—liver cancer	0.00208	0.00359	CbGpPWpGaD
Calcitriol—Dermatitis bullous—Doxorubicin—liver cancer	0.00206	0.0049	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.00204	0.00353	CbGpPWpGaD
Calcitriol—Asthenia—Sorafenib—liver cancer	0.00204	0.00483	CcSEcCtD
Calcitriol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H4—liver cancer	0.00202	0.00349	CbGpPWpGaD
Calcitriol—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—liver cancer	0.00201	0.00347	CbGpPWpGaD
Calcitriol—Pruritus—Sorafenib—liver cancer	0.00201	0.00477	CcSEcCtD
Calcitriol—Blood creatinine increased—Epirubicin—liver cancer	0.002	0.00474	CcSEcCtD
Calcitriol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—liver cancer	0.00198	0.00343	CbGpPWpGaD
Calcitriol—Dehydration—Epirubicin—liver cancer	0.00198	0.00471	CcSEcCtD
Calcitriol—Pain in extremity—Doxorubicin—liver cancer	0.00197	0.00469	CcSEcCtD
Calcitriol—Abdominal pain upper—Epirubicin—liver cancer	0.00195	0.00463	CcSEcCtD
Calcitriol—Diarrhoea—Sorafenib—liver cancer	0.00194	0.00461	CcSEcCtD
Calcitriol—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.00192	0.00456	CcSEcCtD
Calcitriol—CYP24A1—Biological oxidations—GSTP1—liver cancer	0.00191	0.0033	CbGpPWpGaD
Calcitriol—Nasopharyngitis—Epirubicin—liver cancer	0.00191	0.00453	CcSEcCtD
Calcitriol—CYP24A1—Metapathway biotransformation—GSTP1—liver cancer	0.00188	0.00325	CbGpPWpGaD
Calcitriol—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—liver cancer	0.00186	0.00321	CbGpPWpGaD
Calcitriol—Blood creatinine increased—Doxorubicin—liver cancer	0.00185	0.00439	CcSEcCtD
Calcitriol—Dehydration—Doxorubicin—liver cancer	0.00184	0.00436	CcSEcCtD
Calcitriol—VDR—Validated transcriptional targets of TAp63 isoforms—CDKN1A—liver cancer	0.00183	0.00316	CbGpPWpGaD
Calcitriol—Pancreatitis—Epirubicin—liver cancer	0.00181	0.00429	CcSEcCtD
Calcitriol—Vomiting—Sorafenib—liver cancer	0.0018	0.00428	CcSEcCtD
Calcitriol—Abdominal pain upper—Doxorubicin—liver cancer	0.0018	0.00428	CcSEcCtD
Calcitriol—Rash—Sorafenib—liver cancer	0.00179	0.00425	CcSEcCtD
Calcitriol—Dermatitis—Sorafenib—liver cancer	0.00179	0.00424	CcSEcCtD
Calcitriol—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00178	0.00422	CcSEcCtD
Calcitriol—Headache—Sorafenib—liver cancer	0.00178	0.00422	CcSEcCtD
Calcitriol—Nasopharyngitis—Doxorubicin—liver cancer	0.00176	0.00419	CcSEcCtD
Calcitriol—CYP24A1—Biological oxidations—GSTM1—liver cancer	0.00175	0.00303	CbGpPWpGaD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—liver cancer	0.00173	0.003	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—HGF—liver cancer	0.00173	0.003	CbGpPWpGaD
Calcitriol—CYP24A1—Metapathway biotransformation—GSTM1—liver cancer	0.00173	0.00299	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.00169	0.00292	CbGpPWpGaD
Calcitriol—Nausea—Sorafenib—liver cancer	0.00168	0.004	CcSEcCtD
Calcitriol—VDR—Retinoic acid receptors-mediated signaling—AKT1—liver cancer	0.00168	0.00291	CbGpPWpGaD
Calcitriol—CYP3A4—Xenobiotics—CYP2E1—liver cancer	0.00168	0.0029	CbGpPWpGaD
Calcitriol—Pancreatitis—Doxorubicin—liver cancer	0.00167	0.00397	CcSEcCtD
Calcitriol—Weight decreased—Epirubicin—liver cancer	0.00167	0.00396	CcSEcCtD
Calcitriol—CYP24A1—Biological oxidations—CYP1A1—liver cancer	0.00166	0.00287	CbGpPWpGaD
Calcitriol—Drowsiness—Epirubicin—liver cancer	0.00164	0.0039	CcSEcCtD
Calcitriol—CYP24A1—Metapathway biotransformation—CYP1A1—liver cancer	0.00164	0.00283	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.00163	0.00282	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—NR1H4—liver cancer	0.00163	0.00281	CbGpPWpGaD
Calcitriol—CYP3A4—Tamoxifen metabolism—CYP2E1—liver cancer	0.00162	0.00279	CbGpPWpGaD
Calcitriol—CYP3A4—Aflatoxin activation and detoxification—GGT1—liver cancer	0.00161	0.00278	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—NR1I3—liver cancer	0.0016	0.00276	CbGpPWpGaD
Calcitriol—Conjunctivitis—Epirubicin—liver cancer	0.0016	0.00379	CcSEcCtD
Calcitriol—Urinary tract infection—Epirubicin—liver cancer	0.0016	0.00379	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—PCNA—liver cancer	0.00158	0.00273	CbGpPWpGaD
Calcitriol—Weight decreased—Doxorubicin—liver cancer	0.00154	0.00366	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.00153	0.00264	CbGpPWpGaD
Calcitriol—Drowsiness—Doxorubicin—liver cancer	0.00152	0.00361	CcSEcCtD
Calcitriol—Haemoglobin—Epirubicin—liver cancer	0.00148	0.00352	CcSEcCtD
Calcitriol—Conjunctivitis—Doxorubicin—liver cancer	0.00148	0.00351	CcSEcCtD
Calcitriol—Urinary tract infection—Doxorubicin—liver cancer	0.00148	0.00351	CcSEcCtD
Calcitriol—Haemorrhage—Epirubicin—liver cancer	0.00148	0.0035	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—BCL2L1—liver cancer	0.00147	0.00253	CbGpPWpGaD
Calcitriol—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—liver cancer	0.00144	0.00249	CbGpPWpGaD
Calcitriol—GC—Metabolism—CPT1B—liver cancer	0.00141	0.00244	CbGpPWpGaD
Calcitriol—GC—Metabolism—GLUL—liver cancer	0.00141	0.00244	CbGpPWpGaD
Calcitriol—Erythema multiforme—Epirubicin—liver cancer	0.0014	0.00331	CcSEcCtD
Calcitriol—CYP3A4—Estrogen metabolism—GSTM1—liver cancer	0.00139	0.00239	CbGpPWpGaD
Calcitriol—Haemoglobin—Doxorubicin—liver cancer	0.00137	0.00326	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—MET—liver cancer	0.00137	0.00236	CbGpPWpGaD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—JUN—liver cancer	0.00137	0.00236	CbGpPWpGaD
Calcitriol—Haemorrhage—Doxorubicin—liver cancer	0.00137	0.00324	CcSEcCtD
Calcitriol—GC—Metabolism—NR1H4—liver cancer	0.00136	0.00235	CbGpPWpGaD
Calcitriol—GC—Metabolism—GSTA3—liver cancer	0.00134	0.00231	CbGpPWpGaD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—liver cancer	0.00132	0.00229	CbGpPWpGaD
Calcitriol—Arrhythmia—Epirubicin—liver cancer	0.00132	0.00313	CcSEcCtD
Calcitriol—CYP3A4—Estrogen metabolism—CYP1A1—liver cancer	0.00131	0.00227	CbGpPWpGaD
Calcitriol—Erythema multiforme—Doxorubicin—liver cancer	0.00129	0.00307	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—APC—liver cancer	0.00129	0.00222	CbGpPWpGaD
Calcitriol—Erythema—Epirubicin—liver cancer	0.00128	0.00305	CcSEcCtD
Calcitriol—CYP3A4—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.00128	0.00221	CbGpPWpGaD
Calcitriol—CYP3A4—Irinotecan Pathway—APC—liver cancer	0.00126	0.00217	CbGpPWpGaD
Calcitriol—Dysgeusia—Epirubicin—liver cancer	0.00126	0.00299	CcSEcCtD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.00125	0.00216	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—UGDH—liver cancer	0.00124	0.00215	CbGpPWpGaD
Calcitriol—GC—Metabolism—GSTA4—liver cancer	0.00122	0.00211	CbGpPWpGaD
Calcitriol—Arrhythmia—Doxorubicin—liver cancer	0.00122	0.0029	CcSEcCtD
Calcitriol—CYP3A4—Xenobiotics—CYP1A1—liver cancer	0.00121	0.00209	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.0012	0.00207	CbGpPWpGaD
Calcitriol—GC—Metabolism—GSTA2—liver cancer	0.00119	0.00206	CbGpPWpGaD
Calcitriol—Erythema—Doxorubicin—liver cancer	0.00119	0.00282	CcSEcCtD
Calcitriol—Agitation—Epirubicin—liver cancer	0.00118	0.0028	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—EPT1—liver cancer	0.00117	0.00202	CbGpPWpGaD
Calcitriol—Dysgeusia—Doxorubicin—liver cancer	0.00116	0.00276	CcSEcCtD
Calcitriol—CYP3A4—Tamoxifen metabolism—CYP1A1—liver cancer	0.00116	0.00201	CbGpPWpGaD
Calcitriol—GC—Metabolism—GSTA1—liver cancer	0.00115	0.00199	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—MMP2—liver cancer	0.00114	0.00197	CbGpPWpGaD
Calcitriol—GC—Metabolism—NAT2—liver cancer	0.00114	0.00197	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—SERPINE1—liver cancer	0.00112	0.00193	CbGpPWpGaD
Calcitriol—Convulsion—Epirubicin—liver cancer	0.00111	0.00264	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—TAT—liver cancer	0.00111	0.00192	CbGpPWpGaD
Calcitriol—Hypertension—Epirubicin—liver cancer	0.00111	0.00263	CcSEcCtD
Calcitriol—VDR—Generic Transcription Pathway—HNF4A—liver cancer	0.00111	0.00192	CbGpPWpGaD
Calcitriol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.0011	0.0019	CbGpPWpGaD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—MYC—liver cancer	0.0011	0.0019	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.00109	0.00189	CbGpPWpGaD
Calcitriol—Myalgia—Epirubicin—liver cancer	0.00109	0.0026	CcSEcCtD
Calcitriol—Chest pain—Epirubicin—liver cancer	0.00109	0.0026	CcSEcCtD
Calcitriol—Agitation—Doxorubicin—liver cancer	0.00109	0.00259	CcSEcCtD
Calcitriol—GC—Metabolism—ALDOB—liver cancer	0.00109	0.00188	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.00109	0.00188	CbGpPWpGaD
Calcitriol—Anxiety—Epirubicin—liver cancer	0.00109	0.00259	CcSEcCtD
Calcitriol—Discomfort—Epirubicin—liver cancer	0.00108	0.00257	CcSEcCtD
Calcitriol—Dry mouth—Epirubicin—liver cancer	0.00107	0.00254	CcSEcCtD
Calcitriol—Anaphylactic shock—Epirubicin—liver cancer	0.00105	0.00249	CcSEcCtD
Calcitriol—GC—Metabolism—CRABP1—liver cancer	0.00104	0.0018	CbGpPWpGaD
Calcitriol—CYP3A4—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.00104	0.00179	CbGpPWpGaD
Calcitriol—Convulsion—Doxorubicin—liver cancer	0.00103	0.00245	CcSEcCtD
Calcitriol—Hypertension—Doxorubicin—liver cancer	0.00103	0.00244	CcSEcCtD
Calcitriol—Skin disorder—Epirubicin—liver cancer	0.00102	0.00242	CcSEcCtD
Calcitriol—Myalgia—Doxorubicin—liver cancer	0.00101	0.0024	CcSEcCtD
Calcitriol—Chest pain—Doxorubicin—liver cancer	0.00101	0.0024	CcSEcCtD
Calcitriol—Anxiety—Doxorubicin—liver cancer	0.00101	0.00239	CcSEcCtD
Calcitriol—Discomfort—Doxorubicin—liver cancer	0.001	0.00237	CcSEcCtD
Calcitriol—Anorexia—Epirubicin—liver cancer	0.000999	0.00237	CcSEcCtD
Calcitriol—Dry mouth—Doxorubicin—liver cancer	0.00099	0.00235	CcSEcCtD
Calcitriol—VDR—Gene Expression—EXOSC2—liver cancer	0.000984	0.0017	CbGpPWpGaD
Calcitriol—Anaphylactic shock—Doxorubicin—liver cancer	0.00097	0.0023	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000955	0.00227	CcSEcCtD
Calcitriol—Insomnia—Epirubicin—liver cancer	0.000948	0.00225	CcSEcCtD
Calcitriol—CYP3A4—Biological oxidations—UGDH—liver cancer	0.000944	0.00163	CbGpPWpGaD
Calcitriol—Skin disorder—Doxorubicin—liver cancer	0.000942	0.00224	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000937	0.00162	CbGpPWpGaD
Calcitriol—Somnolence—Epirubicin—liver cancer	0.000932	0.00221	CcSEcCtD
Calcitriol—Anorexia—Doxorubicin—liver cancer	0.000925	0.0022	CcSEcCtD
Calcitriol—Decreased appetite—Epirubicin—liver cancer	0.000911	0.00216	CcSEcCtD
Calcitriol—GC—Metabolism—HPGDS—liver cancer	0.00091	0.00157	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000904	0.00156	CbGpPWpGaD
Calcitriol—Constipation—Epirubicin—liver cancer	0.000896	0.00213	CcSEcCtD
Calcitriol—Pain—Epirubicin—liver cancer	0.000896	0.00213	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000884	0.0021	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—JUN—liver cancer	0.000881	0.00152	CbGpPWpGaD
Calcitriol—Insomnia—Doxorubicin—liver cancer	0.000877	0.00208	CcSEcCtD
Calcitriol—CYP3A4—Tryptophan metabolism—CYP2E1—liver cancer	0.000863	0.00149	CbGpPWpGaD
Calcitriol—Somnolence—Doxorubicin—liver cancer	0.000862	0.00205	CcSEcCtD
Calcitriol—Gastrointestinal pain—Epirubicin—liver cancer	0.000857	0.00204	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—CDKN1A—liver cancer	0.000854	0.00148	CbGpPWpGaD
Calcitriol—Decreased appetite—Doxorubicin—liver cancer	0.000843	0.002	CcSEcCtD
Calcitriol—Urticaria—Epirubicin—liver cancer	0.000833	0.00198	CcSEcCtD
Calcitriol—Constipation—Doxorubicin—liver cancer	0.000829	0.00197	CcSEcCtD
Calcitriol—Pain—Doxorubicin—liver cancer	0.000829	0.00197	CcSEcCtD
Calcitriol—Abdominal pain—Epirubicin—liver cancer	0.000829	0.00197	CcSEcCtD
Calcitriol—Body temperature increased—Epirubicin—liver cancer	0.000829	0.00197	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000824	0.00142	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000816	0.00141	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000813	0.00141	CbGpPWpGaD
Calcitriol—GC—Metabolism—PSMD10—liver cancer	0.000811	0.0014	CbGpPWpGaD
Calcitriol—GC—Metabolism—PSMA4—liver cancer	0.000811	0.0014	CbGpPWpGaD
Calcitriol—Gastrointestinal pain—Doxorubicin—liver cancer	0.000793	0.00188	CcSEcCtD
Calcitriol—GC—Metabolism—GOT2—liver cancer	0.000789	0.00136	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—NR1H4—liver cancer	0.000783	0.00135	CbGpPWpGaD
Calcitriol—Hypersensitivity—Epirubicin—liver cancer	0.000772	0.00183	CcSEcCtD
Calcitriol—Urticaria—Doxorubicin—liver cancer	0.000771	0.00183	CcSEcCtD
Calcitriol—VDR—Gene Expression—NR1I3—liver cancer	0.00077	0.00133	CbGpPWpGaD
Calcitriol—Abdominal pain—Doxorubicin—liver cancer	0.000767	0.00182	CcSEcCtD
Calcitriol—Body temperature increased—Doxorubicin—liver cancer	0.000767	0.00182	CcSEcCtD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—AKT1—liver cancer	0.000761	0.00131	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—GLUL—liver cancer	0.000754	0.0013	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—CPT1B—liver cancer	0.000754	0.0013	CbGpPWpGaD
Calcitriol—Asthenia—Epirubicin—liver cancer	0.000752	0.00179	CcSEcCtD
Calcitriol—Pruritus—Epirubicin—liver cancer	0.000742	0.00176	CcSEcCtD
Calcitriol—GC—Metabolism—CYP2E1—liver cancer	0.000742	0.00128	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—NR1H4—liver cancer	0.000727	0.00126	CbGpPWpGaD
Calcitriol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000722	0.00125	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000718	0.00124	CbGpPWpGaD
Calcitriol—Diarrhoea—Epirubicin—liver cancer	0.000717	0.0017	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—GSTA3—liver cancer	0.000715	0.00123	CbGpPWpGaD
Calcitriol—Hypersensitivity—Doxorubicin—liver cancer	0.000715	0.0017	CcSEcCtD
Calcitriol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000698	0.00121	CbGpPWpGaD
Calcitriol—Asthenia—Doxorubicin—liver cancer	0.000696	0.00165	CcSEcCtD
Calcitriol—GC—Metabolism—CYCS—liver cancer	0.000694	0.0012	CbGpPWpGaD
Calcitriol—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000689	0.00119	CbGpPWpGaD
Calcitriol—Pruritus—Doxorubicin—liver cancer	0.000686	0.00163	CcSEcCtD
Calcitriol—GC—Metabolism—GOT1—liver cancer	0.000681	0.00118	CbGpPWpGaD
Calcitriol—GC—Metabolism—GGT1—liver cancer	0.000681	0.00118	CbGpPWpGaD
Calcitriol—Vomiting—Epirubicin—liver cancer	0.000667	0.00158	CcSEcCtD
Calcitriol—Diarrhoea—Doxorubicin—liver cancer	0.000664	0.00158	CcSEcCtD
Calcitriol—Rash—Epirubicin—liver cancer	0.000661	0.00157	CcSEcCtD
Calcitriol—Dermatitis—Epirubicin—liver cancer	0.00066	0.00157	CcSEcCtD
Calcitriol—Headache—Epirubicin—liver cancer	0.000657	0.00156	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—GSTA4—liver cancer	0.000654	0.00113	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000639	0.0011	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—GSTA2—liver cancer	0.000637	0.0011	CbGpPWpGaD
Calcitriol—Nausea—Epirubicin—liver cancer	0.000623	0.00148	CcSEcCtD
Calcitriol—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.00062	0.00107	CbGpPWpGaD
Calcitriol—Vomiting—Doxorubicin—liver cancer	0.000617	0.00146	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—GSTA1—liver cancer	0.000615	0.00106	CbGpPWpGaD
Calcitriol—GC—Metabolism—GSTP1—liver cancer	0.000612	0.00106	CbGpPWpGaD
Calcitriol—Rash—Doxorubicin—liver cancer	0.000612	0.00145	CcSEcCtD
Calcitriol—Dermatitis—Doxorubicin—liver cancer	0.000611	0.00145	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—NAT2—liver cancer	0.000608	0.00105	CbGpPWpGaD
Calcitriol—Headache—Doxorubicin—liver cancer	0.000608	0.00144	CcSEcCtD
Calcitriol—GC—Metabolism—HMOX1—liver cancer	0.000603	0.00104	CbGpPWpGaD
Calcitriol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000597	0.00103	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000584	0.00101	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—ALDOB—liver cancer	0.000583	0.00101	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—PPARA—liver cancer	0.000582	0.00101	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—TP53—liver cancer	0.000582	0.00101	CbGpPWpGaD
Calcitriol—Nausea—Doxorubicin—liver cancer	0.000576	0.00137	CcSEcCtD
Calcitriol—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000566	0.000977	CbGpPWpGaD
Calcitriol—GC—Metabolism—GSTM1—liver cancer	0.000562	0.000971	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—CRABP1—liver cancer	0.000556	0.00096	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.000552	0.000953	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.000542	0.000937	CbGpPWpGaD
Calcitriol—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.000535	0.000924	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—HNF4A—liver cancer	0.000534	0.000922	CbGpPWpGaD
Calcitriol—GC—Metabolism—CYP1A1—liver cancer	0.000533	0.000921	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—ESR1—liver cancer	0.000528	0.000912	CbGpPWpGaD
Calcitriol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000501	0.000866	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.0005	0.000864	CbGpPWpGaD
Calcitriol—GC—Metabolism—MTHFR—liver cancer	0.000497	0.000858	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.000496	0.000857	CbGpPWpGaD
Calcitriol—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000495	0.000855	CbGpPWpGaD
Calcitriol—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000489	0.000845	CbGpPWpGaD
Calcitriol—GC—Metabolism—PPARA—liver cancer	0.000487	0.000842	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—HPGDS—liver cancer	0.000486	0.000839	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000483	0.000835	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000483	0.000834	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—PPARG—liver cancer	0.000481	0.000832	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—PSMD10—liver cancer	0.000467	0.000806	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—PSMA4—liver cancer	0.000467	0.000806	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000466	0.000806	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000461	0.000797	CbGpPWpGaD
Calcitriol—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.000455	0.000786	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.00044	0.00076	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	0.000438	0.000756	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000434	0.00075	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—SERPINE1—liver cancer	0.000434	0.000749	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PSMD10—liver cancer	0.000433	0.000748	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PSMA4—liver cancer	0.000433	0.000748	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—GOT2—liver cancer	0.000421	0.000728	CbGpPWpGaD
Calcitriol—GC—Metabolism—PIK3CG—liver cancer	0.000417	0.000721	CbGpPWpGaD
Calcitriol—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000406	0.000702	CbGpPWpGaD
Calcitriol—GC—Metabolism—PPARG—liver cancer	0.000403	0.000696	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—CYP2E1—liver cancer	0.000396	0.000684	CbGpPWpGaD
Calcitriol—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000387	0.000668	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000383	0.000662	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—CYCS—liver cancer	0.000371	0.00064	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000369	0.000637	CbGpPWpGaD
Calcitriol—GC—Metabolism—PIK3CD—liver cancer	0.000367	0.000634	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—GOT1—liver cancer	0.000364	0.000628	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—GGT1—liver cancer	0.000364	0.000628	CbGpPWpGaD
Calcitriol—GC—Metabolism—ALB—liver cancer	0.000362	0.000626	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—GSTP1—liver cancer	0.000327	0.000564	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—HMOX1—liver cancer	0.000322	0.000556	CbGpPWpGaD
Calcitriol—GC—Metabolism—PIK3CB—liver cancer	0.00032	0.000552	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—H2AFX—liver cancer	0.000315	0.000545	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000301	0.000519	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—GSTM1—liver cancer	0.0003	0.000518	CbGpPWpGaD
Calcitriol—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.000296	0.000512	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—CYP1A1—liver cancer	0.000285	0.000492	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—PPARA—liver cancer	0.00028	0.000484	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000276	0.000477	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—MYC—liver cancer	0.000274	0.000474	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—MTHFR—liver cancer	0.000265	0.000458	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PPARA—liver cancer	0.00026	0.00045	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—MAPK14—liver cancer	0.000259	0.000447	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—ESR1—liver cancer	0.000254	0.000439	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.000248	0.000428	CbGpPWpGaD
Calcitriol—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	0.000244	0.000422	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	0.000234	0.000404	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—PPARG—liver cancer	0.000232	0.0004	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—GSTM1—liver cancer	0.000228	0.000393	CbGpPWpGaD
Calcitriol—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	0.000225	0.000388	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PIK3CG—liver cancer	0.000223	0.000385	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—CYP1A1—liver cancer	0.000216	0.000373	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PPARG—liver cancer	0.000215	0.000372	CbGpPWpGaD
Calcitriol—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	0.000213	0.000368	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—SERPINE1—liver cancer	0.000209	0.000361	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PIK3CD—liver cancer	0.000196	0.000338	CbGpPWpGaD
Calcitriol—GC—Metabolism—PIK3CA—liver cancer	0.000195	0.000337	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—ALB—liver cancer	0.000193	0.000334	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PIK3CB—liver cancer	0.000171	0.000295	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—UGDH—liver cancer	0.000161	0.000279	CbGpPWpGaD
Calcitriol—GC—Metabolism—AKT1—liver cancer	0.000159	0.000275	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—EPT1—liver cancer	0.000152	0.000262	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—TAT—liver cancer	0.000144	0.000249	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—MYC—liver cancer	0.000132	0.000228	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PIK3CA—liver cancer	0.000104	0.00018	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—GLUL—liver cancer	9.78e-05	0.000169	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—CPT1B—liver cancer	9.78e-05	0.000169	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—NR1H4—liver cancer	9.43e-05	0.000163	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—GSTA3—liver cancer	9.27e-05	0.00016	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—AKT1—liver cancer	9.16e-05	0.000158	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—AKT1—liver cancer	8.5e-05	0.000147	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—GSTA4—liver cancer	8.48e-05	0.000147	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—GSTA2—liver cancer	8.27e-05	0.000143	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—GSTA1—liver cancer	7.98e-05	0.000138	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—NAT2—liver cancer	7.89e-05	0.000136	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—ALDOB—liver cancer	7.56e-05	0.000131	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—CRABP1—liver cancer	7.21e-05	0.000125	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—HPGDS—liver cancer	6.3e-05	0.000109	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PSMA4—liver cancer	5.62e-05	9.71e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PSMD10—liver cancer	5.62e-05	9.71e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—GOT2—liver cancer	5.47e-05	9.44e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—CYP2E1—liver cancer	5.14e-05	8.88e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—CYCS—liver cancer	4.81e-05	8.31e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—GOT1—liver cancer	4.72e-05	8.15e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—GGT1—liver cancer	4.72e-05	8.15e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—GSTP1—liver cancer	4.24e-05	7.32e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—HMOX1—liver cancer	4.18e-05	7.22e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—GSTM1—liver cancer	3.89e-05	6.73e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—CYP1A1—liver cancer	3.69e-05	6.38e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—MTHFR—liver cancer	3.44e-05	5.95e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PPARA—liver cancer	3.38e-05	5.83e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PIK3CG—liver cancer	2.89e-05	5e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PPARG—liver cancer	2.79e-05	4.82e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PIK3CD—liver cancer	2.54e-05	4.39e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—ALB—liver cancer	2.51e-05	4.34e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PIK3CB—liver cancer	2.22e-05	3.83e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PIK3CA—liver cancer	1.35e-05	2.33e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—AKT1—liver cancer	1.1e-05	1.91e-05	CbGpPWpGaD
